Image

L19IL2/TNF in Patients With Basal Cell Carcinoma

Join a basal cell carcinoma clinical trial with L19IL2/TNF.

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)
L19IL2/TNF in Patients With Basal Cell Carcinoma is a medical study designed for people with advanced basal cell carcinoma (BCC), a type of skin cancer. This study is for those who cannot be treated with other typical medicines. The treatment uses two proteins, L19IL2 and L19TNF, injected directly into the tumors once a week for up to 4 weeks. If the cancer responds well, more treatment may be given. Key Points:
  • Participants may have treatments weekly for up to 4 weeks, with possible additional rounds.
  • Regular check-ups and tumor assessments are required over a period of up to 160 weeks.
  • Patients must be willing to provide tissue samples and follow all study procedures.
To join, participants must have a specific stage of BCC and meet certain health conditions. Women of childbearing age and men with partners must use contraception. The study excludes anyone with other active cancers, severe infections, or certain heart, liver, or lung conditions.
Print
Study details
    Locally Advanced Basal Cell Carcinoma

NCT07227870

Philogen S.p.A.

17 October 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.